Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 15 Similar Profiles
Therapeutics Medicine & Life Sciences
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
Small Cell Lung Carcinoma Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Platinum Medicine & Life Sciences
Survival Medicine & Life Sciences
Lung Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2006 2022

Research Output 2005 2017

7 Citations

Advances in Small Cell Lung Cancer

Kalemkerian, G. P. & Schneider, B. J. Feb 1 2017 In : Hematology/Oncology Clinics of North America. 31, 1, p. 143-156 14 p.

Research output: Research - peer-reviewReview article

Small Cell Lung Carcinoma
Cranial Irradiation
Neuroendocrine Tumors

Phase II Trial of Dose-dense Pemetrexed, Gemcitabine, and Bevacizumab in Patients With Advanced, Non–Small-cell Lung Cancer

Schneider, B. J., Kalemkerian, G. P., Gadgeel, S. M., Valdivieso, M., Hackstock, D. M., Chen, W., Heilbrun, L. K., Ruckdeschel, J. C. & Wozniak, A. J. May 1 2017 In : Clinical Lung Cancer. 18, 3, p. 299-302 4 p.

Research output: Research - peer-reviewArticle

Non-Small Cell Lung Carcinoma
Confidence Intervals
1 Citations

Phase I study of epigenetic priming with azacitidine prior to standard neoadjuvant chemotherapy for patients with resectable gastric and esophageal adenocarcinoma: Evidence of tumor hypomethylation as an indicator of major histopathologic response

Schneider, B. J., Shah, M. A., Klute, K., Ocean, A., Popa, E., Altorki, N., Lieberman, M., Schreiner, A., Yantiss, R., Christos, P. J., Palmer, R., You, D., Viale, A., Kermani, P. & Scandura, J. M. Jun 1 2017 In : Clinical Cancer Research. 23, 11, p. 2673-2680 8 p.

Research output: Research - peer-reviewArticle

Drug Therapy
8 Citations

Systemic therapy for stage IV non–small-cell lung cancer: American Society of clinical oncology clinical practice guideline update

Hanna, N., Johnson, D., Temin, S., Baker, S., Brahmer, J., Ellis, P. M., Giaccone, G., Hesketh, P. J., Jaiyesimi, I., Leighl, N. B., Riely, G. J., Schiller, J. H., Schneider, B. J., Smith, T. J., Tashbar, J., Biermann, W. A. & Masters, G. Oct 20 2017 In : Journal of Clinical Oncology. 35, 30, p. 3484-3515 32 p.

Research output: Research - peer-reviewArticle

Medical Oncology
Practice Guidelines
Non-Small Cell Lung Carcinoma
Drug Therapy
2 Citations

Therapy of Small Cell Lung Cancer (SCLC) with a Topoisomerase-I–inhibiting Antibody–Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab Govitecan

Gray, J. E. , Heist, R. S. , Starodub, A. N. , Ross Camidge, D. , Kio, E. A. , Masters, G. A. , Thomas Purcell, W. , Guarino, M. J. , Misleh, J. , Schneider, C. J. , Schneider, B. J. , Ocean, A. , Johnson, T. , Gandhi, L. , Kalinsky, K. , Scheff, R. , Messersmith, W. A. , Govindan, S. V. , Maliakal, P. P. , Mudenda, B. & 3 others Wegener, W. A., Sharkey, R. M. & Goldenberg, D. M. Oct 1 2017 In : Clinical Cancer Research. 23, 19, p. 5711-5719 9 p.

Research output: Research - peer-reviewArticle

Type I DNA Topoisomerase
Small Cell Lung Carcinoma
Drug Delivery Systems